CLOV
Income statement / Annual
Last year (2023), Clover Health Investments, Corp.'s total revenue was $2.03 B,
a decrease of 41.50% from the previous year.
In 2023, Clover Health Investments, Corp.'s net income was -$213.36 M.
See Clover Health Investments, Corp.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$2.03 B
|
$3.48 B
|
$1.47 B
|
$672.89 M
|
$462.27 M
|
$281.02 M
|
| Cost of Revenue |
$1.78 B |
$3.45 B |
$1.55 B |
$590.47 M |
$449.70 M |
$0.00 |
| Gross Profit |
$257.33 M |
$22.74 M |
-$79.18 M |
$82.42 M |
$12.57 M |
$281.02 M |
| Gross Profit Ratio |
0.13 |
0.01 |
-0.05 |
0.12 |
0.03 |
1 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$186.43 M
|
$486.64 M
|
$445.75 M
|
$191.70 M
|
$187.33 M
|
$103.04 M
|
| Selling & Marketing
Expenses |
$258.30 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$84.24 M
|
| Selling, General &
Administrative Expenses |
$444.73 M
|
$486.64 M
|
$445.75 M
|
$191.70 M
|
$187.33 M
|
$187.28 M
|
| Other Expenses |
$21.15 M |
-$92.98 M |
$112.07 M |
-$16.57 M |
$8.44 M |
$0.00 |
| Operating Expenses |
$1.99 B |
$393.66 M |
$557.81 M |
$175.13 M |
$195.76 M |
$476.00 M |
| Cost And Expenses |
$2.24 B |
$3.85 B |
$2.11 B |
$765.60 M |
$645.47 M |
$476.00 M |
| Interest Income |
$0.00 |
$1.36 M |
$16.91 M |
$117,255.00 |
$39.07 M |
$6.95 M |
| Interest Expense |
$7,000.00 |
$1.36 M |
$16.91 M |
$57.11 M |
$39.07 M |
$0.00 |
| Depreciation &
Amortization |
$2.51 M
|
$1.19 M
|
$1.25 M
|
$555,000.00
|
$551,000.00
|
$185.80 M
|
| EBITDA |
-$210.85 M
|
-$337.02 M
|
-$569.60 M
|
-$78.73 M
|
-$182.65 M
|
-$16.13 M
|
| EBITDA Ratio |
-0.1 |
-0.11 |
-0.43 |
-0.14 |
-0.4 |
-0.06 |
| Operating Income Ratio
|
-0.1
|
-0.11
|
-0.43
|
-0.14
|
-0.4
|
-0.66
|
| Total Other
Income/Expenses Net |
-$4.82 M
|
$32.08 M
|
$49.24 M
|
-$43.69 M
|
-$180.54 M
|
-$16.13 M
|
| Income Before Tax |
-$213.36 M |
-$338.84 M |
-$587.76 M |
-$91.58 M |
-$363.74 M |
-$201.93 M |
| Income Before Tax Ratio
|
-0.1
|
-0.1
|
-0.4
|
-0.14
|
-0.79
|
-0.72
|
| Income Tax Expense |
$0.00 |
-$33.44 M |
$16.91 M |
$57.11 M |
$39.07 M |
-$16.13 M |
| Net Income |
-$213.36 M |
-$305.40 M |
-$604.67 M |
-$148.69 M |
-$402.81 M |
-$201.93 M |
| Net Income Ratio |
-0.1 |
-0.09 |
-0.41 |
-0.22 |
-0.87 |
-0.72 |
| EPS |
-0.44 |
-0.64 |
-1.46 |
-1.68 |
-3.89 |
-4.81 |
| EPS Diluted |
-0.44 |
-0.64 |
-1.46 |
-1.68 |
-3.89 |
-4.81 |
| Weighted Average Shares
Out |
$482.18 M
|
$476.24 M
|
$412.92 M
|
$88.69 M
|
$103.50 M
|
$42.01 M
|
| Weighted Average Shares
Out Diluted |
$482.18 M
|
$476.24 M
|
$412.92 M
|
$88.69 M
|
$103.50 M
|
$42.01 M
|
| Link |
|
|
|
|
|
|
